tirzepatide mcas A new American study explored how GLP‑1 medications (like semaglutide or tirzepatide) might affect symptoms. Researchers didn't set out to study MCAS: they simply noticed that some patients who were prescribed Tirzepatide reduces food intake and

The trend shows that GLP-1 consumers still enjoy indulgent food, just less of it, said Stephanie Mattucci, principal strategist, Mintel

But we can do better

How GLP-1 Medications Support Long-Term Weight Management GLP-1 receptor agonists have been studied extensively in adults seeking a safe and predictable method to manage weight

The dose is gradually increased to minimize side effects: Weeks 1-4: 2.5 mg weekly (starting dose) Weeks 5-8: 5 mg weekly Weeks 9-12: 7.5 mg weekly (if tolerated) Weeks 13-16: 10 mg weekly Week 17+: 12.5-15 mg weekly (maximum dose, if needed) Your provider will adjust the titration schedule based on your response and tolerability

Gastrointestinal side effects Ozempic and alcohol can cause some of the same side effects